Literature DB >> 28079762

Robotic Versus Laparoscopic Gastric Resection for Primary Gastrointestinal Stromal Tumors >5 cm: A Size-Matched and Location-Matched Comparison.

Nicola de'Angelis1, Pietro Genova, Aurelien Amiot, Cecile Charpy, Mara Disabato, Ajay P Belgaumkar, Ali Chahrour, Francois Legou, Daniel Azoulay, Francesco Brunetti.   

Abstract

This study compared robotic (RR) and laparoscopic resection (LR) for primary gastrointestinal stromal tumors (GISTs) of the stomach >5 cm. Twelve consecutive patients who underwent RR from 2012 to 2015 were matched for tumor size and location with 24 patients who underwent LR from 2000 to 2012. The median tumor size was 7.1 cm (range, 5.5 to 11.5). GISTs were resected by wedge resection (91.7%) or distal gastrectomy. The median RR operative time was longer than that of LR (162.5 vs. 130 min, respectively; P=0.004). Only 1 LR patient required conversion. The time to flatus and hospital stay were similar between groups. Overall, 3 patients developed minor postoperative complications that were medically treated. Mortality was nil. All resections were R0. No difference was observed in the incidence of recurrence. RR was significantly more expensive (+21.6%) than LR. RR appears to be safe and feasible for GISTs>5 cm, but is associated with longer operative times and greater costs.

Entities:  

Mesh:

Year:  2017        PMID: 28079762     DOI: 10.1097/SLE.0000000000000371

Source DB:  PubMed          Journal:  Surg Laparosc Endosc Percutan Tech        ISSN: 1530-4515            Impact factor:   1.719


  2 in total

Review 1.  Minimally invasive surgery for gastric gastrointestinal stromal tumors.

Authors:  Ye-Xin Koh; Brian K P Goh
Journal:  Transl Gastroenterol Hepatol       Date:  2017-12-12

2.  Which method of distal pancreatectomy is cost-effective among open, laparoscopic, or robotic surgery?

Authors:  Maylis Rodriguez; Riccardo Memeo; Piera Leon; Fabrizio Panaro; Stylianos Tzedakis; Ornella Perotto; Sharmini Varatharajah; Nicola de'Angelis; Pietro Riva; Didier Mutter; Francis Navarro; Jacques Marescaux; Patrick Pessaux
Journal:  Hepatobiliary Surg Nutr       Date:  2018-10       Impact factor: 7.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.